Featured Chrome Extensions:

Casey IRACs are produced by an AI that analyzes the opinion’s content to construct its analysis. While we strive for accuracy, the output may not be flawless. For a complete and precise understanding, please refer to the linked opinions above.

Keywords

liabilitypatent

Related Cases

State of Idaho v. I.C.C., 939 F.2d 784
View Case »
Knoxville TVA Employees Credit Union v. Hill, Not Reported in S.W. Rptr., 2022 WL 4242870
View Case »
Hilton Davis Chemical Co. v. Warner-Jenkinson Co., Inc., 62 F.3d 1512, 64 USLW 2109, 35 U.S.P.Q.2d 1641
View Case »
Pennsylvania Coal Co. v. Mahon, 260 U.S. 393, 43 S.Ct. 158, 67 L.Ed. 322, 28 A.L.R. 1321
View Case »
Kiobel v. Royal Dutch Petroleum Co., 569 U.S. 108, 133 S.Ct. 1659, 185 L.Ed.2d 671, 81 USLW 4241, 13 Cal. Daily Op. Serv. 3743, 2013 Daily Journal D.A.R. 4933, 24 Fla. L. Weekly Fed. S 142
View Case »
Justia Law Link
LexisNexis Link
Westlaw Link
CourtListener Link
Oyez Link

Life Technologies Corp. v. Promega Corp., 580 U.S. 140, 137 S.Ct. 734, 197 L.Ed.2d 33, 85 USLW 4049, 121 U.S.P.Q.2d 1641, 17 Cal. Daily Op. Serv. 1585, 2017 Daily Journal D.A.R. 1566, 26 Fla. L. Weekly Fed. S 434

Facts

Sublicensee of patent for genetic testing toolkits, by supplying from the United States an enzyme known as Taq polymerase, which was one of the five components for sublicensee's toolkits that the sublicensee manufactured abroad, did not supply a 'substantial portion' of the components of a multicomponent invention, as could give rise to liability for active inducement of patent infringement by supplying from the United States all or a substantial portion of the components of a patented invention for combination abroad.

Issue

Rule

Analysis

Conclusion

Who won?

You must be